Literature DB >> 31700172

Toward a broader response to cardiometabolic disease.

Johanna Ralston1, Rachel Nugent2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31700172     DOI： 10.1038/s41591-019-0642-9

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

Review 1.  Circulating Microbiota in Cardiometabolic Disease.

Authors:  Keiichi Sumida; Zhongji Han; Chi-Yang Chiu; Tahliyah S Mims; Amandeep Bajwa; Ryan T Demmer; Susmita Datta; Csaba P Kovesdy; Joseph F Pierre
Journal:  Front Cell Infect Microbiol       Date:  2022-05-03       Impact factor: 6.073

2.  Characterizing a Common CERS2 Polymorphism in a Mouse Model of Metabolic Disease and in Subjects from the Utah CAD Study.

Authors:  Rebekah J Nicholson; Annelise M Poss; J Alan Maschek; James E Cox; Paul N Hopkins; Steven C Hunt; Mary C Playdon; William L Holland; Scott A Summers
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 6.134

Review 3.  Obesity, SDGs and ROOTS: a Framework for Impact.

Authors:  Johanna Ralston; Katy Cooper; Jaynaide Powis
Journal:  Curr Obes Rep       Date:  2021-01-20

4.  The influence of nutritional state on the fatty acid composition of circulating lipid fractions: implications for their use as biomarkers of dietary fat intake.

Authors:  Sion A Parry; Fredrik Rosqvist; Sarah Peters; Rebecca K Young; Thomas Cornfield; Pamela Dyson; Leanne Hodson
Journal:  Ups J Med Sci       Date:  2021-07-13       Impact factor: 2.384

5.  The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect.

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2021-11-24       Impact factor: 9.951

Review 6.  The Role of Tumor Necrosis Factor Associated Factors (TRAFs) in Vascular Inflammation and Atherosclerosis.

Authors:  Mark Colin Gissler; Peter Stachon; Dennis Wolf; Timoteo Marchini
Journal:  Front Cardiovasc Med       Date:  2022-02-17

7.  Effects of potential risk factors on the development of cardiometabolic multimorbidity and mortality among the elders in China.

Authors:  Huihui Zhang; Xinyu Duan; Peixi Rong; Yusong Dang; Mingxin Yan; Yaling Zhao; Fangyao Chen; Jing Zhou; Yulong Chen; Duolao Wang; Leilei Pei
Journal:  Front Cardiovasc Med       Date:  2022-09-09

Review 8.  Cardiometabolic Risk Factors in Pregnancy and Implications for Long-Term Health: Identifying the Research Priorities for Low-Resource Settings.

Authors:  Shobhana Nagraj; Stephen H Kennedy; Robyn Norton; Vivekananda Jha; Devarsetty Praveen; Lisa Hinton; Jane E Hirst
Journal:  Front Cardiovasc Med       Date:  2020-03-20

Review 9.  Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet).

Authors:  Manuela Casula; Alberico Luigi Catapano; Paolo Magni
Journal:  Nutrients       Date:  2022-01-30       Impact factor: 5.717

10.  Coronavirus Disease 2019 and Cardiometabolic Disease.

Authors:  Chan W Kim; Wilbert S Aronow; William H Frishman
Journal:  Cardiol Rev       Date:  2022 May-Jun 01       Impact factor: 2.644
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.